How much does Central Pharma Contract Packing Limited make?

Central Pharma Contract Packing Limited reported revenue of £17.9m and £237k profit in the year to 31 Dec 2025, according to its accounts filed at Companies House.

How many employees does Central Pharma Contract Packing Limited have?

Central Pharma Contract Packing Limited reported an average of 195 employees in the year to 31 Dec 2025.

Is Central Pharma Contract Packing Limited profitable?

Yes — Central Pharma Contract Packing Limited reported a profit of £237k in the year to 31 Dec 2025.

Company No. 05666241 · Incorporated 4 Jan 2006

Central Pharma Contract Packing Limited

Registered name: CENTRAL PHARMA CONTRACT PACKING LIMITED

Part of Central Pharma Contract Holdings Limited group

Central Pharma Contract Packing Limited made £17.9m revenue and £237k profit in the year to 31 Dec 2025.

Central Pharma Contract Packing Limited’s revenue fell 1% to £17.9m in the year to 31 Dec 2025, with £237k profit and 195 employees. The company is classified under “packaging activities” and is based in Bedford; we hold 5 years of its filed accounts.

Full P&L filedSection N · Administrative and support servicesSIC 82920Packaging activities

Status: Active
Location: Bedford, South East
Age: 20 yrs · since 2006
Type: Private Limited Company

Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.

Latest accounts · year to 31 Dec 2025

Key figures

Revenue

£17.9m

Growth ▼0.5%

Profit

£237k

Growth ▲332.4%

Profit margin

1.3%

Gross 38.1%

Employees

195

Change ▼11.8%

Profit / employee

£1.2k

Revenue/employee £91.8k

Profitable streak

2yrs

Consecutive profitable years in our data

Badges are automated estimates derived from the filed figures — not statements of fact about the company.

5 filed years

Financial history

Multi-year financials, oldest to newest
Year to	31 Dec 2021	31 Dec 2022	31 Dec 2023	31 Dec 2024	31 Dec 2025
Disclosure	Full P&L	Full P&L	Full P&L	Full P&L	Full P&L
Profit & loss
Revenue (turnover)	£16.5m	£18.6m	£17.8m	£18m	£17.9m
Cost of sales	£10.1m	£12.2m	£11m	£10.6m	£11.1m
Gross profit	£6.3m	£6.5m	£6.7m	£7.4m	£6.8m
Operating profit	£425k	−£510k	−£565k	£374k	£577k
Profit before tax	£345k	−£698k	−£804k	£178k	£347k
Profit after tax	£249k	−£584k	−£650k	£54.8k	£237k
Profit (best available)	£249k	−£584k	−£650k	£54.8k	£237k
Staff costs	£6.5m	£7m	£7.2m	£7.9m	£8.2m
Employees (average)	214	231	209	221	195
Ratios
Profit margin	1.5%	−3.1%	−3.7%	0.3%	1.3%
Gross margin	38.5%	34.8%	37.9%	41%	38.1%
Revenue per employee	£77k	£80.7k	£85k	£81.4k	£91.8k
Profit per employee	£1.2k	−£2.5k	−£3.1k	£248	£1.2k
Growth (year on year)
Revenue growth	—	▲13.1%	▼4.7%	▲1.3%	▼0.5%
Profit growth	—	▼334.6%	—	—	▲332.4%
Headcount growth	—	▲7.9%	▼9.5%	▲5.7%	▼11.8%
Balance sheet — indirect signals, not revenue
Cash at bank	£720	£720	£438	£435	£110k
Net assets	—	—	£2m	£2.1m	£2.3m
Fixed assets	£4m	£3.5m	£3.1m	£2.7m	£2.3m
Current assets	£8.7m	£9.3m	£10.4m	£8.3m	£9.2m
Debtors	£3.2m	£2.8m	£2.5m	£1.9m	£2.3m
Source	FullAccounts · bulk data Oct 2023	FullAccounts · bulk data Oct 2023	FullAccounts · bulk data Nov 2024	FullAccounts · bulk data Sep 2025	FullAccounts · bulk data Sep 2026

Derived from the latest filing

How the business works

Profit margin: 1.3%; Profit ÷ revenue.
Gross margin: 38.1%; Gross profit ÷ revenue. High for software and services.
Revenue per employee: £91.8k; Revenue ÷ average employees.
Profit per employee: £1.2k; Profit ÷ average employees.
Cash conversion: —; Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
Fixed assets ÷ revenue: 12.9%; Capital intensity. Low = capital-light, cheaper to start.
Deferred income ÷ revenue: —; Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
Debtors ÷ revenue: 13.1%; Money owed by customers. Low = customers pay quickly.

Indirect — not revenue

Balance-sheet signals

Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.

Net assets: ▲11%; Now £2.3m
Cash at bank: ▲25297%; Now £110k
Headcount: ▼12%; Now 195
Deferred income: —; Now —
Fixed assets: ▼14%; Now £2.3m

Corporate ownership

Group structure

Ownership chain

Central Pharma Contract Holdings Limitedultimate parent75–100%
Central Pharma Contract Packing Limitedthis company

Bands show the share of ownership each company holds in the one below it.

Sister companies (3)

Central Pharma Biotechnica LimitedRev. £563k · Profit −£307k
Central Pharma Cell and Gene Therapy LtdRev. £513k · Profit −£292k
Central Pharma Manufacturing LtdFigures not disclosed

From the Persons with Significant Control register (corporate controllers only).

Same industry, similar size

Similar profitable businesses

Industry benchmarks →

Sources

Companies House profile Filing history & original accounts

Latest figures from FullAccounts for the year to 31 Dec 2025 (profit £237k), from the Companies House accounts bulk data published Sep 2026. Spotted an error? Request a correction.

Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.